References
Chan JK, Jaffe ES, Ralfkiaer E (2001) Extranodal NK/T-cell lymphoma, nasal type. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) Tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 204–207
Kwong YL (2005) Natural killer-cell malignancies: diagnosis and treatment. Leukemia 19:2186–2194 doi:10.1038/sj.leu.2403955
Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH et al (1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89:4501–4513
Yamaguchi M, Suzuki R, Kwong YL, Kim WS, Hasegawa Y, Izutsu K et al (2008) Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 99:1016–1020 doi:10.1111/j.1349-7006.2008.00768.x
Chim CS, Ma SY, Au WY, Choy C, Lie AK, Liang R et al (2004) Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 103:216–221 doi:10.1182/blood-2003-05-1401
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tse, E., Leung, R., Khong, PL. et al. Non-nasal natural killer cell lymphoma: not non-nasal after all. Ann Hematol 88, 185–187 (2009). https://doi.org/10.1007/s00277-008-0562-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-008-0562-0